CSIMarket
 


Nanoviricides inc   (NNVC)
Other Ticker:  
 
 

NNVC's EPS Net Growth by Quarter and Year

Nanoviricides Inc 's EPS Net results by quarter and year




NNVC EPS Net (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - -0.30 -0.15 -0.18
III Quarter March - -0.15 -0.16 -0.19
II Quarter December -0.18 -0.15 -0.17 -0.22
I Quarter September -0.17 -0.14 -0.23 -0.22
FY   -0.35 -0.74 -0.71 -0.81



NNVC EPS Net second quarter 2024 Y/Y Growth Comment
Nanoviricides inc in the second quarter 2024 recorded EPS net loss of $ -0.18 .

According to the results reported in the second quarter 2024, Nanoviricides Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Nanoviricides Inc ' s EPS Net no change of % ranks overall at the positon no. in the second quarter 2024.




NNVC EPS Net ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Nanoviricides Inc 's second quarter 2024 EPS Net $ -0.18 NNVC's Income Statement
Nanoviricides Inc 's second quarter 2023 EPS Net $ -0.15 Quarterly NNVC's Income Statement
New: More NNVC's historic EPS Net Growth >>


NNVC EPS Net (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




EPS Net second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Nanoviricides Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NNVC's II. Quarter Q/Q EPS Net Comment
II. Quarter 2024 results of -0.18 by Nanoviricides inc come out even worse if you take a look at -0.17 EPS net loss in the first quarter.

Within Major Pharmaceutical Preparations industry Nanoviricides inc achieved highest sequential EPS Net growth. While Nanoviricides Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NNVC's II. Quarter Q/Q EPS Net Comment
Recent results of -0.18 by Nanoviricides inc come out even less good considering the -0.17 EPS net loss a quarter before.

Within Major Pharmaceutical Preparations industry Nanoviricides inc achieved highest sequential EPS Net growth. While Nanoviricides Inc 's EPS Net growth quarter on quarter, overall rank is .


Nanoviricides Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS Net 12 Months Ending $ -0.80 $ -0.77 $ -0.74 $ -0.59 $ -0.60
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Nanoviricides Inc ' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Dec 31 2023 period.
The business is getting worse as the cumulative EPS net loss is becoming larger from $ -0.77 in the twelve months ending a quarter before and $ -0.62401517813486 for the twelve months ending in the quarter a year ago.

Nanoviricides inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Nanoviricides Inc ' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Dec 31 2023 period.
The business is detiriorating as the cumulative EPS net loss is getting bigger from $ -0.77 in TTM ending quarter Sep 30 2023 and $ -0.62401517813486 from the TTM period ending Dec 31 2022.

Nanoviricides inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
NNVC's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for NNVC's Competitors
EPS Net Growth for Nanoviricides Inc 's Suppliers
EPS Net Growth for NNVC's Customers

You may also want to know
NNVC's Annual Growth Rates NNVC's Profitability Ratios NNVC's Asset Turnover Ratio NNVC's Dividend Growth
NNVC's Roe NNVC's Valuation Ratios NNVC's Financial Strength Ratios NNVC's Dividend Payout Ratio
NNVC's Roa NNVC's Inventory Turnover Ratio NNVC's Growth Rates NNVC's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2023
Baxter International Inc 34.83%$ 34.825 
West Pharmaceutical Services Inc 34.80%$ 34.797 
National Research Corporation34.48%$ 34.481 
Semler Scientific Inc 33.61%$ 33.610 
Viemed Healthcare Inc 32.99%$ 32.987 
Tactile Systems Technology Inc 30.65%$ 30.651 
The Pennant Group Inc 29.62%$ 29.622 
Option Care Health Inc 25.48%$ 25.476 
Orasure Technologies Inc22.04%$ 22.039 
Inmode Ltd 21.69%$ 21.693 
Icon Plc20.72%$ 20.718 
Conmed Corporation17.88%$ 17.881 
Vertex Pharmaceuticals Inc17.53%$ 17.534 
Zoetis Inc 15.51%$ 15.514 
Steris Plc14.52%$ 14.516 
Medpace Holdings Inc 13.12%$ 13.116 
Eli Lilly And Company12.87%$ 12.869 
Idexx Laboratories Inc11.69%$ 11.686 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com